⌘K

09:31:59·168d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Maravai LifeSciences Holdings Inc.

ByQuantisnow·Wall Street's wire, on your screen.

MRVI· Maravai LifeSciences Holdings Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

MRVI
Maravai LifeSciences Holdings Inc.
Health Care

Recent analyst ratings

Feb 26UpdateRobert W. Baird$3.00
Dec 19UpdateGuggenheim-
Dec 5UpdateGoldman$4.25
Nov 14UpdateWolfe Research-
Nov 8UpdateWilliam Blair-
Aug 28UpdateWells Fargo$10.00

Related

SEC4d
SEC Form DEFA14A filed by Maravai LifeSciences Holdings Inc.
SEC7d
SEC Form DEF 14A filed by Maravai LifeSciences Holdings Inc.
PR11d
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
INSIDER45d
Officer Dolan Christine covered exercise/tax liability with 28,661 shares, decreasing direct ownership by 6% to 420,312 units (SEC Form 4)
INSIDER45d
General Counsel Oreshack Kurt covered exercise/tax liability with 39,976 shares, decreasing direct ownership by 9% to 384,991 units (SEC Form 4)
SEC64d
SEC Form 10-K filed by Maravai LifeSciences Holdings Inc.
SEC65d
Maravai LifeSciences Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
PR65d
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results